Paliperidone
- Product NDC
- 69367-435
- 11-digit product format
- 693670435
- Labeler code
- 69367
- Product ID
- 69367-435_10e430a8-a911-4b08-8efb-694387c50531
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Paliperidone
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Westminster Pharmaceuticals, LLC
- Application
- ANDA218755
- Marketing category
- ANDA
- Marketing start
- 2025-12-09
- Substance
- PALIPERIDONE
- Active strength
- 9 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218755-001 | PALIPERIDONE | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | |
| A218755-002 | PALIPERIDONE | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | |
| A218755-003 | PALIPERIDONE | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | |
| A218755-004 | PALIPERIDONE | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218755-001 | AB |
| A218755-002 | AB |
| A218755-003 | AB |
| A218755-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A218755-001 | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218755-002 | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218755-003 | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218755-004 | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-001 | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-002 | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-003 | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-004 | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-001 | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-002 | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-003 | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-004 | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-001 | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-002 | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-003 | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-004 | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A218755-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218755-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218755-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218755-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-004 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-003 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-004 | AB | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Paliperidone
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PALIPERIDONE | 9 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 838F01T721 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69367-435-30 | Paliperidone | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69367-435-30 | EA - Each | 69367-435 | 1bd4cc46-d9d1-4aa2-9b2f-a5b983562b5d | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Paliperidone | PALIPERIDONE | Bryant Ranch Prepack | ff5ef11c-5c22-4a8e-89dd-4740f0ebf634 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| Paliperidone | PALIPERIDONE | Bryant Ranch Prepack | f75e884e-1883-45d7-ac9b-4a6c63f2185e | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| Paliperidone | PALIPERIDONE | Bryant Ranch Prepack | f0c13f91-0232-48b0-aa13-121805b8da13 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| Paliperidone | PALIPERIDONE | Bryant Ranch Prepack | c7472b50-fa6c-4127-a4b3-3645436274ee | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| Paliperidone | PALIPERIDONE | Westminster Pharmaceuticals, LLC | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 69367-435 |
| PALIPERIDONE | PALIPERIDONE | Eskayef Pharmaceuticals Limited | de95e29f-a030-4777-a601-874500ab8e91 | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 672571 | paliperidone 9 MG 24HR Extended Release Oral Tablet | PSN | f0c13f91-0232-48b0-aa13-121805b8da13 | 100 |
| 672571 | 24 HR paliperidone 9 MG Extended Release Oral Tablet | SCD | f0c13f91-0232-48b0-aa13-121805b8da13 | 100 |
| 672571 | paliperidone 9 MG 24 HR Extended Release Oral Tablet | SY | f0c13f91-0232-48b0-aa13-121805b8da13 | 100 |
| 866103 | paliperidone 1.5 MG 24HR Extended Release Oral Tablet | PSN | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672567 | paliperidone 3 MG 24HR Extended Release Oral Tablet | PSN | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672569 | paliperidone 6 MG 24HR Extended Release Oral Tablet | PSN | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672571 | paliperidone 9 MG 24HR Extended Release Oral Tablet | PSN | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 866103 | 24 HR paliperidone 1.5 MG Extended Release Oral Tablet | SCD | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672567 | 24 HR paliperidone 3 MG Extended Release Oral Tablet | SCD | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672569 | 24 HR paliperidone 6 MG Extended Release Oral Tablet | SCD | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672571 | 24 HR paliperidone 9 MG Extended Release Oral Tablet | SCD | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 866103 | paliperidone 1.5 MG 24 HR Extended Release Oral Tablet | SY | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672567 | paliperidone 3 MG 24 HR Extended Release Oral Tablet | SY | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672569 | paliperidone 6 MG 24 HR Extended Release Oral Tablet | SY | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
| 672571 | paliperidone 9 MG 24 HR Extended Release Oral Tablet | SY | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 69367-435-30 | 69367043530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-435-30) | 2025-12-09 | No | No | Current |